Terms: = Endocrine gland cancer AND FLI1, SIC-1, 2313, ENSG00000151702, Q01543, EWSR2 AND Clinical Outcome
3 results:
1. Analysis of factors influencing the clinical outcome after surgery and
Li Y; Rao M; Zheng C; Huang J; Fang D; Xiong Y; Yuan G
Front Endocrinol (Lausanne); 2022; 13():1015798. PubMed ID: 36313750
[TBL] [Abstract] [Full Text] [Related]
2. Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.
Nan X; Wang J; Cheng H; Yin Z; Sheng J; Qiu B; Lau CC; Yustein JT; Zhao H; Wong STC
Cancer Lett; 2020 Jan; 469():195-206. PubMed ID: 31672491
[TBL] [Abstract] [Full Text] [Related]
3. Oncogenic Fli-1 is a potential prognostic marker for the progression of epithelial ovarian cancer.
Song W; Hu L; Li W; Wang G; Li Y; Yan L; Li A; Cui J
BMC Cancer; 2014 Jun; 14():424. PubMed ID: 24923303
[TBL] [Abstract] [Full Text] [Related]